阻断TXNIP降低了IL-1β诱导的冠状细胞细胞炎症
Shenggui Xu1, Weimin Lin2, Wang Lin3
1Department of Orthopaedics, Mindong Hospital Affiliated to Fujian Medical University, Fuan, China. xshgui@sina.cn.
Cellular and molecular biology (Noisy-le-Grand, France)
|January 27, 2024
概括
这项研究表明,沉默TXNIP在冠状细胞减少细胞亡和衰老,促进细胞增殖在骨关节炎模型. 需要进一步的研究,以充分阐明涉及的分子机制.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 骨关节炎 (OA) 是一种普遍存在的退行性关节疾病,其特征是关节软骨的破坏.
- 干白素1β (IL-1β) 在状细胞损伤和OA进展中起着关键作用.
- TXNIP (铁素相互作用蛋白) 涉及到细胞压力和炎症,但其在OA中的作用尚未完全理解.
研究的目的:
- 调查TXNIP在IL-1β诱导的冠状细胞损伤和OA进展中的作用.
- 阐明TXNIP调节状细胞亡,衰老和增殖的分子机制.
- 评估OA中TXNIP抑制的治疗潜力.
主要方法:
- 原始小鼠冠状细胞被培养并用IL-1β治疗.
- 使用免疫组织化学和qRT-PCR分析了TXNIP表达.
- 使用lentiviral载体 (shTXNIP) 沉默了TXNIP.
- 细胞增殖,细胞亡和衰老使用CCK-8测定,流细胞计和染色套件进行了评估.
- 炎症标记物 (TNF,IL-6),矩阵降解酶 (MMP3,MMP13,ADAMTS-5),II型原蛋白和信号蛋白 (P-ERK,NLRP3,Caspase1) 的基因和蛋白质表达通过RT-PCR和西部涂抹进行了分析.
主要成果:
- 治疗IL-1β会以剂量依赖的方式增加冠状细胞中的TXNIP表达.
- 抑制TXNIP显著增强了冠状细胞的增殖.
- 抑制TXNIP可降低IL-1β诱导的慢性细胞亡和衰老.
- 降低TXNIP的调节降低了促炎基因 (TNF,IL-6) 和矩阵降解酶 (MMP3,MMP13,ADAMTS-5) 的表达,并增加了II型原体的表达.
- 虽然P-ERK表达在很大程度上保持不变,但在TXNIP沉默后NLRP3和Caspase1蛋白水平降低.
结论:
- TXNIP在IL-1β诱导的状细胞亡和衰老中发挥着关键作用.
- 沉默TXNIP表明对冠状细胞有保护作用,促进增殖和减少退行性标记物.
- 抑制TXNIP代表了对骨关节炎的潜在治疗策略.
- 在OA中由TXNIP调节的精确分子信号通路需要进一步调查.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


